IRIS
LATRONICO, TIZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.196
EU - Europa 648
AS - Asia 275
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.125
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.188
CN - Cina 256
SE - Svezia 195
IT - Italia 146
DE - Germania 70
UA - Ucraina 66
FI - Finlandia 43
FR - Francia 41
GB - Regno Unito 35
BE - Belgio 15
SG - Singapore 13
IE - Irlanda 9
CA - Canada 8
CZ - Repubblica Ceca 8
RU - Federazione Russa 8
NL - Olanda 6
AU - Australia 4
JP - Giappone 3
HU - Ungheria 2
IN - India 2
AT - Austria 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
KR - Corea 1
PE - Perù 1
PL - Polonia 1
Totale 3.125
Salva come PNG Salva come JPEG
Città #
Woodbridge 274
Chandler 259
Fairfield 214
Houston 164
Nyköping 164
Ashburn 162
Jacksonville 145
Ann Arbor 144
Wilmington 98
Cambridge 85
Seattle 84
Beijing 60
Bari 57
Lawrence 49
Roxbury 47
Nanjing 38
New York 35
Marseille 33
Boardman 28
Des Moines 26
Spongano 17
Jiaxing 16
Brussels 15
Brooklyn 14
Princeton 13
Inglewood 12
Falls Church 11
Guangzhou 10
Munich 10
San Diego 10
Shenyang 10
Singapore 10
Dublin 9
Hebei 9
Shanghai 9
Wuhan 9
Changsha 8
Los Angeles 8
Auburn Hills 7
Nanchang 7
Tianjin 7
Amsterdam 6
Paris 6
Adelfia 5
Brno 5
Giovinazzo 5
Scottsdale 5
Washington 5
Dearborn 4
Wuxi 4
Brooks 3
Helsinki 3
Irpin 3
London 3
Milan 3
Palermo 3
San Francisco 3
Taranto 3
Toronto 3
Aversa 2
Gothenburg 2
Grafing 2
Heze 2
Indiana 2
Jinan 2
Kilburn 2
Lecce 2
Melbourne 2
Miskolc 2
Molfetta 2
Ningbo 2
Norwalk 2
Olomouc 2
Sydney 2
Taizhou 2
Triggiano 2
Zhengzhou 2
Augusta 1
Bergamo 1
Boston 1
Brampton 1
Brindisi 1
Capua 1
Cerignola 1
Ceska 1
Chiswick 1
Chizhou 1
Foshan 1
Fuzhou 1
Hanover 1
Hounslow 1
Hyderabad 1
Jinhua 1
Jining 1
Kansas City 1
Kunming 1
Leawood 1
Lima 1
Matera 1
Messina 1
Totale 2.518
Salva come PNG Salva come JPEG
Nome #
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 163
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 110
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 106
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 98
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 95
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 95
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 91
null 91
null 90
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 89
null 87
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 80
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 76
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 75
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 71
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 70
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 70
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 64
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 62
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 61
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 59
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 57
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 57
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 56
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 56
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 53
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 53
Matrix Metalloproteinases in CNS Inflammation. 50
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 50
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 48
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 48
null 47
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 46
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 46
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 44
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 44
The effects of dietary antioxidants on gelatinase activity in cultured rat astrocytes. implications for the complementary treatment of multiple sclerosis. 44
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 40
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 33
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 31
High surface area mesoporous silica nanoparticles with tunable size in the sub-micrometer regime: Insights on the size and porosity control mechanisms 31
Interferon-Beta Treatment Inhibits Matrix metalloproteinases in rat glial cell cultures 29
Inhibition of calpain activity and expression by interferon-beta in rat astrocytes: implications for MS pathogenesis and treatment. 29
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 28
Interferon-alpha/beta treatment inhibits metalloproteinase activity in rat astrocyte cell cultures 26
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 25
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 24
Unravelling the relevance of fad synthetase in human physiopathology. A biotechnological approach. 24
null 21
DEVELOPMENTAL OMEGA-3 SUPPLEMENTATION IMPROVES MOTOR SKILLS IN JUVENILE RATS 21
Impact of manganese neurotoxicity on MMP-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 20
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 19
Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies 19
null 18
Differential Modulation of NF-κ B in Neurons and Astrocytes Underlies Neuroprotection and Antigliosis Activity of Natural Antioxidant Molecules 15
null 15
null 14
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 13
Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation 12
Inhibitory effect of immunomodulatory and immunosuppressive therapies on the activity of gelatinases and urokinase-type plasminogen activator in peripheral blood mononuclear cells from patients with multiple sclerosis 12
null 11
Lead exposure of rats during and after pregnancy induces anti-myelin proteolytic activity: a potential mechanism for lead-induced neurotoxicity 10
Use of a commercial feed supplement based on yeast products and microalgae with or without nucleotide addition in calves 8
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects 8
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients 8
Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species 8
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases 7
Intra- and interspecific variation in electrophoretic profiles of Tethya spp.: an integration to morfological classification system 7
Molecular mechanisms of cell toxicity and Matrix Metalloproteinase-9 inhibition by Antiretroviral Drugs in Cultured Primary Astrocytes. 7
Antioxidant Activity of Polysaccharides from the Edible Mushroom Pleurotus eryngii 6
Neuroprotective Effect of Resveratrol against Manganese-Induced Oxidative Stress and Matrix Metalloproteinase-9 in an “In Vivo” Model of Neurotoxicity 4
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19 3
Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives 3
Resveratrol impinges on retrograde communication without inducing mitochondrial biogenesis in aged rat soleus muscle 2
Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia 2
COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality 2
Totale 3.217
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020468 0 35 14 49 55 30 54 42 64 55 63 7
2020/2021395 39 14 37 15 43 12 33 34 48 66 42 12
2021/2022373 10 51 2 5 19 24 12 20 49 29 54 98
2022/2023770 77 79 56 68 89 98 9 93 131 41 15 14
2023/2024294 17 50 14 61 24 65 4 2 5 13 6 33
2024/2025130 111 19 0 0 0 0 0 0 0 0 0 0
Totale 3.217